Clinical Trial Update: Stem Cell Transplant Therapy With Campath-1H for Treating Advanced Mycosis Fungoides and Sezary Syndrome [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluated Campath-1H–mediated stem cell transplant therapy for advanced Mycosis Fungoides and Sezary Syndrome; the study has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mycosis Fungoides
• Sezary Syndrome

Drugs mentioned

• Campath-1H (alemtuzumab)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Mycosis Fungoides, Sezary Syndrome | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-02-24